These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas. Schwartz DA; White CM; Wise PE; Herline AJ Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987 [TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051 [TBL] [Abstract][Full Text] [Related]
7. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720 [TBL] [Abstract][Full Text] [Related]
8. Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's disease. Rasul I; Wilson SR; MacRae H; Irwin S; Greenberg GR Am J Gastroenterol; 2004 Jan; 99(1):82-8. PubMed ID: 14687146 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease. Zhu M; Xu X; Feng Q; Cui Z; Wang T; Yan Y; Ran Z Dig Dis Sci; 2021 May; 66(5):1658-1668. PubMed ID: 32524415 [TBL] [Abstract][Full Text] [Related]
12. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. West RL; van der Woude CJ; Hansen BE; Felt-Bersma RJ; van Tilburg AJ; Drapers JA; Kuipers EJ Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1329-36. PubMed ID: 15606395 [TBL] [Abstract][Full Text] [Related]
16. Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging. Bell SJ; Halligan S; Windsor AC; Williams AB; Wiesel P; Kamm MA Aliment Pharmacol Ther; 2003 Feb; 17(3):387-93. PubMed ID: 12562451 [TBL] [Abstract][Full Text] [Related]
17. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431 [TBL] [Abstract][Full Text] [Related]
18. Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy. Lahat A; Assulin Y; Beer-Gabel M; Chowers Y J Crohns Colitis; 2012 Apr; 6(3):311-6. PubMed ID: 22405167 [TBL] [Abstract][Full Text] [Related]
19. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report. van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797 [TBL] [Abstract][Full Text] [Related]
20. Infliximab and surgical treatment of complex anal Crohn's disease. Duff S; Sagar PM; Rao M; Dolling S; Sprakes M; Hamlin PJ Colorectal Dis; 2012 Aug; 14(8):972-6. PubMed ID: 21899707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]